vs
Side-by-side financial comparison of MICROVISION, INC. (MVIS) and PureTech Health plc (PRTC). Click either name above to swap in a different company.
MICROVISION, INC. is the larger business by last-quarter revenue ($223.0K vs $180.0K, roughly 1.2× PureTech Health plc).
MicroVision Inc. is a technology company specializing in advanced LiDAR sensors, miniature display solutions, and perception software. Its core products serve automotive ADAS, augmented reality devices, consumer electronics, and industrial automation markets, delivering high-precision, low-power sensing technologies for next-generation smart applications.
PureTech Health plcPRTCEarnings & Financial Report
PureTech Health is an American biotechnology company which develops medicines to combat serious diseases. It is listed on the London Stock Exchange.
MVIS vs PRTC — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2023
| Metric | ||
|---|---|---|
| Revenue | $223.0K | $180.0K |
| Net Profit | — | $-41.1M |
| Gross Margin | — | — |
| Operating Margin | — | -38908.9% |
| Net Margin | — | -22820.6% |
| Revenue YoY | -86.5% | — |
| Net Profit YoY | -21.2% | — |
| EPS (diluted) | — | $-0.15 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $223.0K | — | ||
| Q3 25 | $241.0K | — | ||
| Q2 25 | $155.0K | — | ||
| Q1 25 | $589.0K | — | ||
| Q4 24 | $1.6M | — | ||
| Q3 24 | $190.0K | — | ||
| Q2 24 | $1.9M | — | ||
| Q1 24 | $956.0K | — |
| Q4 25 | — | — | ||
| Q3 25 | $-14.2M | — | ||
| Q2 25 | $-14.2M | — | ||
| Q1 25 | $-28.8M | — | ||
| Q4 24 | $-31.2M | — | ||
| Q3 24 | $-15.5M | — | ||
| Q2 24 | $-23.9M | — | ||
| Q1 24 | $-26.3M | — |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | 6.6% | — | ||
| Q4 24 | -149.5% | — | ||
| Q3 24 | — | — | ||
| Q2 24 | 18.2% | — | ||
| Q1 24 | -33.6% | — |
| Q4 25 | — | — | ||
| Q3 25 | -5278.4% | — | ||
| Q2 25 | -9455.5% | — | ||
| Q1 25 | -2383.7% | — | ||
| Q4 24 | -1119.5% | — | ||
| Q3 24 | -8266.3% | — | ||
| Q2 24 | -1296.4% | — | ||
| Q1 24 | -2793.9% | — |
| Q4 25 | — | — | ||
| Q3 25 | -5899.2% | — | ||
| Q2 25 | -9180.0% | — | ||
| Q1 25 | -4886.1% | — | ||
| Q4 24 | -1888.2% | — | ||
| Q3 24 | -8166.8% | — | ||
| Q2 24 | -1259.5% | — | ||
| Q1 24 | -2752.4% | — |
| Q4 25 | — | — | ||
| Q3 25 | $-0.05 | — | ||
| Q2 25 | $-0.06 | — | ||
| Q1 25 | $-0.12 | — | ||
| Q4 24 | $-0.15 | — | ||
| Q3 24 | $-0.07 | — | ||
| Q2 24 | $-0.11 | — | ||
| Q1 24 | $-0.13 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | ||
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $74.9M | $191.1M |
| Total DebtLower is stronger | $19.2M | $0 |
| Stockholders' EquityBook value | $55.5M | $458.2M |
| Total Assets | $103.1M | $694.0M |
| Debt / EquityLower = less leverage | 0.35× | 0.00× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $74.9M | — | ||
| Q3 25 | $99.5M | — | ||
| Q2 25 | $91.4M | — | ||
| Q1 25 | $69.0M | — | ||
| Q4 24 | $74.7M | — | ||
| Q3 24 | $43.2M | — | ||
| Q2 24 | $56.6M | — | ||
| Q1 24 | $73.1M | — |
| Q4 25 | $19.2M | — | ||
| Q3 25 | $29.0M | — | ||
| Q2 25 | $32.3M | — | ||
| Q1 25 | $30.1M | — | ||
| Q4 24 | $33.0M | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $55.5M | — | ||
| Q3 25 | $90.7M | — | ||
| Q2 25 | $77.1M | — | ||
| Q1 25 | $53.2M | — | ||
| Q4 24 | $48.8M | — | ||
| Q3 24 | $65.9M | — | ||
| Q2 24 | $78.7M | — | ||
| Q1 24 | $93.8M | — |
| Q4 25 | $103.1M | — | ||
| Q3 25 | $150.8M | — | ||
| Q2 25 | $140.6M | — | ||
| Q1 25 | $116.7M | — | ||
| Q4 24 | $121.2M | — | ||
| Q3 24 | $88.3M | — | ||
| Q2 24 | $103.4M | — | ||
| Q1 24 | $124.2M | — |
| Q4 25 | 0.35× | — | ||
| Q3 25 | 0.32× | — | ||
| Q2 25 | 0.42× | — | ||
| Q1 25 | 0.57× | — | ||
| Q4 24 | 0.68× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | ||
|---|---|---|
| Operating Cash FlowLast quarter | $-58.7M | $-40.8M |
| Free Cash FlowOCF − Capex | $-59.4M | — |
| FCF MarginFCF / Revenue | -26636.3% | — |
| Capex IntensityCapex / Revenue | 304.5% | 0.0% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-103.1M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-58.7M | — | ||
| Q3 25 | $-16.5M | — | ||
| Q2 25 | $-12.7M | — | ||
| Q1 25 | $-14.1M | — | ||
| Q4 24 | $-15.1M | — | ||
| Q3 24 | $-14.1M | — | ||
| Q2 24 | $-18.6M | — | ||
| Q1 24 | $-20.8M | — |
| Q4 25 | $-59.4M | — | ||
| Q3 25 | $-16.6M | — | ||
| Q2 25 | $-12.9M | — | ||
| Q1 25 | $-14.2M | — | ||
| Q4 24 | $-15.2M | — | ||
| Q3 24 | $-14.1M | — | ||
| Q2 24 | $-18.8M | — | ||
| Q1 24 | $-20.9M | — |
| Q4 25 | -26636.3% | — | ||
| Q3 25 | -6894.6% | — | ||
| Q2 25 | -8346.5% | — | ||
| Q1 25 | -2410.4% | — | ||
| Q4 24 | -918.7% | — | ||
| Q3 24 | -7421.1% | — | ||
| Q2 24 | -989.5% | — | ||
| Q1 24 | -2183.4% | — |
| Q4 25 | 304.5% | — | ||
| Q3 25 | 53.1% | — | ||
| Q2 25 | 134.2% | — | ||
| Q1 25 | 16.8% | — | ||
| Q4 24 | 6.2% | — | ||
| Q3 24 | 4.7% | — | ||
| Q2 24 | 8.7% | — | ||
| Q1 24 | 11.9% | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.